| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 7e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |